Does TUCATINIB Cause Product dose omission issue? 332 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 332 reports of Product dose omission issue have been filed in association with TUCATINIB (TUKYSA). This represents 5.5% of all adverse event reports for TUCATINIB.
332
Reports of Product dose omission issue with TUCATINIB
5.5%
of all TUCATINIB reports
19
Deaths
122
Hospitalizations
How Dangerous Is Product dose omission issue From TUCATINIB?
Of the 332 reports, 19 (5.7%) resulted in death, 122 (36.7%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 332 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Asthenia (322)
Decreased appetite (286)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TUCATINIB Alternatives Have Lower Product dose omission issue Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI